141080 — LigaChem Biosciences Share News
0.000.00%
Last trade - 00:00- KR₩5tn
- KR₩5tn
- KR₩142bn
Brief: Ligachem Biosciences - Issues 2.21 Million New Preferred Shares
Brief: Ligachem Biosciences To Divest 5 Billion Won Worth Of Own Shares
Brief: Ligachem Biosciences To Divest 17 Billion Won Worth Of Own Shares
Brief: Legochem Biosciences To Conduct Capital Increase Of 470 Billion Won For Operational Funds
Brief: LegoChem Biosciences, Amgen Collaborates For Development Of Antibody-Drug Conjugates
Brief: Sotio Exercises Option For Novel Antibody-Drug Conjugate Program Under Agreement With Legochem Biosciences
Brief: NextCure And LegoChem Biosciences Enter Into Collaboration
Brief: HBM Holdings Commenced Collaborations On Antibody-Drug Conjugate Projects
Brief: PharmAbcine Enters Into Research Collaboration Agreement With LegoChem Biosciences
Brief: Legochem Biosciences And Iksuda Enter Licensing Agreement For Antibody Drug Conjugate Program
Brief: LegoChem Biosciences, Takeda Enter into Multi-Target Research Collaboration and License Agreement
Brief: LegoChem Biosciences receives Patent
Brief: LegoChem Biosciences receives U.S. patent
Toymaker Lego reports first annual sales decline in 13 years
Brief: LegoChem Biosciences receives U.S. patent
Brief: LegoChem Biosciences receives patent
Brief: LegoChem Biosciences receives U.S. patent
Brief: LegoChem Biosciences receives patent
Nordic Nanovector sees interest in its Non-Hodgkin Lymphoma treatment (updated)